The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 28, 2023 | Seabaugh Ramona | Chief Financial Officer | Sell(S) | 303 | $5.70 | $2K |
| Sep 1, 2023 | Seabaugh Ramona | Chief Financial Officer | Option exercise(M) | 680 | — | $0 |
| Sep 1, 2023 | Seabaugh Ramona | Chief Financial Officer | Option exercise(M) | 680 | — | $0 |
| Aug 18, 2023 | Seabaugh Ramona | Chief Financial Officer | Grant(A) | 57K | — | $0 |
| Aug 18, 2023 | Seabaugh Ramona | Chief Financial Officer | Grant(A) | 57K | — | $0 |
| Aug 18, 2023 | Doerr Mark Edward | Chief Executive Officer, Director | Grant(A) | 125K | — | $0 |
| Aug 18, 2023 | Doerr Mark Edward | Chief Executive Officer, Director | Grant(A) | 125K | — | $0 |
| Jun 16, 2023 | Ally Bridge MedAlpha Master Fund L.P. | 10% Owner | Other(J) | 6.8M | — | — |
| Jun 16, 2023 | Ally Bridge MedAlpha Master Fund L.P. | 10% Owner | Other(J) | 965K | — | — |
| Jun 16, 2023 | Redmile Group, LLC | Director, 10% Owner | Grant(A) | 38.9M | — | — |
| Jun 16, 2023 | Redmile Group, LLC | Director, 10% Owner | Grant(A) | 38.9M | — | — |
| Jun 15, 2023 | Johnson Paul D | Director | Grant(A) | 545K | — | $0 |
| Jun 15, 2023 | Stettin Glen D. | Director | Grant(A) | 545K | — | $0 |
| Jun 15, 2023 | McGraw Laurie | Director | Grant(A) | 545K | — | $0 |
| Jun 15, 2023 | Kramer Michael R | Director | Grant(A) | 545K | — | $0 |
| Mar 21, 2023 | Seabaugh Ramona | Chief Financial Officer | Sell(S) | 3K | $0.31 | $1K |
| Mar 13, 2023 | Ally Bridge Group (NY) LLC | 10% Owner | Buy(P) | 6.8M | $0.32 | $2.2M |
| Mar 13, 2023 | Ally Bridge Group (NY) LLC | 10% Owner | Buy(P) | 965K | $0.32 | $309K |
| Mar 9, 2023 | Redmile Group, LLC | Director, 10% Owner | Grant(A) | 38.9M | $0.32 | $12.5M |
| Mar 9, 2023 | Redmile Group, LLC | Director, 10% Owner | Grant(A) | 38.9M | $0.32 | $12.5M |
| Mar 6, 2023 | Doerr Mark Edward | Chief Executive Officer, Director | Sell(S) | 73K | $0.31 | $23K |
| Mar 3, 2023 | Doerr Mark Edward | Chief Executive Officer, Director | Sell(S) | 21K | $0.33 | $7K |
| Mar 3, 2023 | Seabaugh Ramona | Chief Financial Officer | Sell(S) | 7K | $0.34 | $2K |
| Mar 1, 2023 | Doerr Mark Edward | Chief Executive Officer, Director | Option exercise(M) | 282K | — | $0 |
| Mar 1, 2023 | Doerr Mark Edward | Chief Executive Officer, Director | Option exercise(M) | 282K | — | $0 |
| Mar 1, 2023 | Seabaugh Ramona | Chief Financial Officer | Option exercise(M) | 20K | — | $0 |
| Mar 1, 2023 | Seabaugh Ramona | Chief Financial Officer | Option exercise(M) | 8K | — | $0 |
| Mar 1, 2023 | Seabaugh Ramona | Chief Financial Officer | Option exercise(M) | 20K | — | $0 |
| Mar 1, 2023 | Seabaugh Ramona | Chief Financial Officer | Option exercise(M) | 8K | — | $0 |
| Jul 1, 2022 | Green Jeremy | Director, 10% Owner | Grant(A) | 7.6M | $1.06 | $8.1M |
| Jul 1, 2022 | Green Jeremy | Director, 10% Owner | Grant(A) | 9.4M | $1.06 | $10.0M |
| Jul 1, 2022 | Green Jeremy | Director, 10% Owner | Grant(A) | 4.7M | — | $0 |
| Jul 1, 2022 | Green Jeremy | Director, 10% Owner | Grant(A) | 3.8M | — | $0 |
| Jun 15, 2022 | Kramer Michael R | Director | Grant(A) | 117K | $1.45 | $169K |
| Jun 15, 2022 | Stettin Glen D. | Director | Grant(A) | 117K | — | $0 |
| Jun 15, 2022 | Gradwell Gerald | Director | Grant(A) | 117K | — | $0 |
| Jun 15, 2022 | Johnson Paul D | Director | Grant(A) | 117K | — | $0 |
| Jun 15, 2022 | McGraw Laurie | Director | Grant(A) | 117K | — | $0 |
| Apr 8, 2022 | Hess Steven | Executive Vice President | Grant(A) | 131K | — | $0 |
| Apr 8, 2022 | Hess Steven | Executive Vice President | Grant(A) | 131K | — | $0 |
| Apr 4, 2022 | Redmile Group, LLC | Director, 10% Owner | Grant(A) | 7.1M | — | $0 |
| Apr 4, 2022 | Redmile Group, LLC | Director, 10% Owner | Grant(A) | 14.1M | $1.06 | $15.0M |
| Apr 4, 2022 | ABG-WTT Global Life Science Capital Partners GP, L.P. | 10% Owner | Buy(P) | 11.1M | $1.06 | $11.8M |
| Apr 4, 2022 | ABG-WTT Global Life Science Capital Partners GP, L.P. | 10% Owner | Buy(P) | 3.0M | $1.06 | $3.2M |
| Apr 4, 2022 | ABG-WTT Global Life Science Capital Partners GP, L.P. | 10% Owner | Buy(P) | 1.5M | $1.06 | $1.6M |
| Apr 4, 2022 | ABG-WTT Global Life Science Capital Partners GP, L.P. | 10% Owner | Buy(P) | 5.6M | $1.06 | $5.9M |
| Mar 16, 2022 | McGraw Laurie | Director | Grant(A) | 86K | — | $0 |
| Mar 16, 2022 | Johnson Paul D | Director | Grant(A) | 86K | — | $0 |
| Mar 16, 2022 | Seabaugh Ramona | Chief Financial Officer | Grant(A) | 60K | — | $0 |
| Mar 16, 2022 | Seabaugh Ramona | Chief Financial Officer | Grant(A) | 60K | — | $0 |
| Feb 9, 2022 | Seabaugh Ramona | Chief Financial Officer | Grant(A) | 25K | — | $0 |
| Feb 9, 2022 | Seabaugh Ramona | Chief Financial Officer | Grant(A) | 25K | — | $0 |
| Jan 10, 2022 | Doerr Mark Edward | Chief Executive Officer, Director | Grant(A) | 1.2M | — | $0 |
| Jan 10, 2022 | Doerr Mark Edward | Chief Executive Officer, Director | Grant(A) | 847K | — | $0 |
| Jun 30, 2021 | Gradwell Gerald | Director | Grant(A) | 18K | — | $0 |
| Jun 30, 2021 | Kramer Michael R | Director | Grant(A) | 18K | — | $0 |
| Jun 30, 2021 | Stettin Glen D. | Director | Grant(A) | 18K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).